These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34926894)

  • 21. The novel antidyskinetic drug sarizotan elicits different functional responses at human D2-like dopamine receptors.
    Kuzhikandathil EV; Bartoszyk GD
    Neuropharmacology; 2006 Sep; 51(4):873-84. PubMed ID: 16844149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current drug treatments targeting dopamine D3 receptor.
    Leggio GM; Bucolo C; Platania CB; Salomone S; Drago F
    Pharmacol Ther; 2016 Sep; 165():164-77. PubMed ID: 27343365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In Vitro and In Silico Characterization of G-Protein Coupled Receptor (GPCR) Targets of Phlorofucofuroeckol-A and Dieckol.
    Paudel P; Seong SH; Park SE; Ryu JH; Jung HA; Choi JS
    Mar Drugs; 2021 Jun; 19(6):. PubMed ID: 34199834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eckol as a Potential Therapeutic against Neurodegenerative Diseases Targeting Dopamine D₃/D₄ Receptors.
    Paudel P; Seong SH; Wu S; Park S; Jung HA; Choi JS
    Mar Drugs; 2019 Feb; 17(2):. PubMed ID: 30744179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of dopamine D4 receptor participation in mouse hyperdopaminergic locomotor response.
    Liao IM; Chen JC
    Behav Brain Res; 2021 Jan; 396():112925. PubMed ID: 32971195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional selectivity of allosteric interactions within G protein-coupled receptor oligomers: the dopamine D1-D3 receptor heterotetramer.
    Guitart X; Navarro G; Moreno E; Yano H; Cai NS; Sánchez-Soto M; Kumar-Barodia S; Naidu YT; Mallol J; Cortés A; Lluís C; Canela EI; Casadó V; McCormick PJ; Ferré S
    Mol Pharmacol; 2014 Oct; 86(4):417-29. PubMed ID: 25097189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Requirement for the endocannabinoid system in social interaction impairment induced by coactivation of dopamine D1 and D2 receptors in the piriform cortex.
    Zenko M; Zhu Y; Dremencov E; Ren W; Xu L; Zhang X
    J Neurosci Res; 2011 Aug; 89(8):1245-58. PubMed ID: 21557291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine D4 receptor ubiquitination.
    Skieterska K; Rondou P; Van Craenenbroeck K
    Biochem Soc Trans; 2016 Apr; 44(2):601-5. PubMed ID: 27068976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. WAY-100635 is a potent dopamine D4 receptor agonist.
    Chemel BR; Roth BL; Armbruster B; Watts VJ; Nichols DE
    Psychopharmacology (Berl); 2006 Oct; 188(2):244-51. PubMed ID: 16915381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolism of kurarinone by human liver microsomes and its effect on cytotoxicity.
    Zhang X; Jiang P; Chen P; Cheng N
    Pharm Biol; 2016; 54(4):619-27. PubMed ID: 26429409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson's disease.
    Scheller D; Ullmer C; Berkels R; Gwarek M; Lübbert H
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Jan; 379(1):73-86. PubMed ID: 18704368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Palmitoylation of the carboxyl-terminal tail of dopamine D
    Zhang X; Kim KM
    Biochem Biophys Res Commun; 2016 Oct; 479(2):398-403. PubMed ID: 27659709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cloning, expression and characterization of a human dopamine D4.2 receptor (CHO K1 cells) and various D4.2/D2L chimeras (COS-7 cells).
    Shih YH; Chung FZ; Pugsley TA
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 Jan; 21(1):153-67. PubMed ID: 9075264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-based ligand discovery targeting orthosteric and allosteric pockets of dopamine receptors.
    Lane JR; Chubukov P; Liu W; Canals M; Cherezov V; Abagyan R; Stevens RC; Katritch V
    Mol Pharmacol; 2013 Dec; 84(6):794-807. PubMed ID: 24021214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacology and Therapeutic Potential of Benzothiazole Analogues for Cocaine Use Disorder.
    Boateng CA; Nilson AN; Placide R; Pham ML; Jakobs FM; Boldizsar N; McIntosh S; Stallings LS; Korankyi IV; Kelshikar S; Shah N; Panasis D; Muccilli A; Ladik M; Maslonka B; McBride C; Sanchez MX; Akca E; Alkhatib M; Saez J; Nguyen C; Kurtyan E; DePierro J; Crowthers R; Brunt D; Bonifazi A; Newman AH; Rais R; Slusher BS; Free RB; Sibley DR; Stewart KD; Wu C; Hemby SE; Keck TM
    J Med Chem; 2023 Sep; 66(17):12141-12162. PubMed ID: 37646374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biased G Protein-Independent Signaling of Dopamine D
    Guitart X; Moreno E; Rea W; Sánchez-Soto M; Cai NS; Quiroz C; Kumar V; Bourque L; Cortés A; Canela EI; Bishop C; Newman AH; Casadó V; Ferré S
    Mol Neurobiol; 2019 Oct; 56(10):6756-6769. PubMed ID: 30919214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epinephrine and norepinephrine act as potent agonists at the recombinant human dopamine D4 receptor.
    Lanau F; Zenner MT; Civelli O; Hartman DS
    J Neurochem; 1997 Feb; 68(2):804-12. PubMed ID: 9003072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of various types of single-polypeptide-chain (sc) heterodimeric A₂AR/D₂R complexes and their allosteric receptor-receptor interactions.
    Kamiya T; Yoshioka K; Nakata H
    Biochem Biophys Res Commun; 2015 Jan; 456(2):573-9. PubMed ID: 25478641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory Effect of Kurarinone on Growth of Human Non-small Cell Lung Cancer: An Experimental Study Both
    Yang J; Chen H; Wang Q; Deng S; Huang M; Ma X; Song P; Du J; Huang Y; Wen Y; Ren Y; Yang X
    Front Pharmacol; 2018; 9():252. PubMed ID: 29628889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of agonist binding to human dopamine receptor subtypes by L-prolyl-L-leucyl-glycinamide and a peptidomimetic analog.
    Verma V; Mann A; Costain W; Pontoriero G; Castellano JM; Skoblenick K; Gupta SK; Pristupa Z; Niznik HB; Johnson RL; Nair VD; Mishra RK
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1228-36. PubMed ID: 16126839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.